+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 35Years - 44Years
FEMALE
ID07871825

Randomized Trial of Granulocyte Colony Stimulating Factor G-CSF for Women with Diminished Ovarian Reserve Undergoing IVF Treatment

Led by Center for Human Reproduction · Updated on 2026-10-13

140

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Granulocyte Colony Stimulating Factor G-CSF to improve outcomes for women with diminished ovarian reserve DOR, a condition characterized by reduced follicle counts and decreased fertility in women undergoing In Vitro Fertilization IVF. The study focuses on women aged 35 years or older within the POSEIDON group 4, who have low anti-Mullerian hormone AMH levels and are undergoing IVF treatment. The goal is to assess whether G-CSF can increase the number of mature eggs and improve IVF success. Participants in this double-blinded randomized trial will receive either five subcutaneous injections of 300 micrograms of G-CSF Neupogen or a saline placebo every other day over a 10-day course starting in the early luteal phase. Following this, all participants will undergo standard ovarian stimulation for IVF in the next menstrual cycle according to clinical protocols. The trial compares the effects of G-CSF versus placebo in addition to standard IVF treatment. During the study, researchers will monitor the total and mature eggs retrieved as the primary outcomes. Secondary outcomes include egg maturation, fertilization rates, number of viable high-quality embryos at days 3 or 5, and clinical pregnancy rates. Safety data will also be collected. The entire study period spans from initial dosing through IVF stimulation and monitoring of outcomes, aiming to provide insights into the impact of G-CSF on ovarian function and IVF results.

CONDITIONS

Brief Title

Study of G-CSF for DOR in Patients Undergoing IVF

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here